New Study Illustrates Biopharmaceutical Industry’s Commitment to Personalized Medicine
26 May 2015
Potential personalized medicines represent 42 percent of drugs in the pipeline. This new finding, from a survey by the Tufts Center for the Study for Drug Development (CSDD), is remarkably high, particularly given that about 15 years ago the science of genomic medicine was just developing and that number was virtually zero.
Biopharmaceutical Companies Recognized as Meaningful Places to Work
26 May 2015
According to Business Insider the scores were calculated considering “high job satisfaction, low job stress, ability to telecommute, high job meaning, experienced median pay/total cash compensation, and salary delta.”
Import Substitution to Cost Russia $50 Billion
25 May 2015
Russia's import substitution program will cost at least 2.5 trillion rubles ($50 billion), news agency RIA Novosti reported Wednesday, citing Industry and Trade Minister Denis Manturov.
FDA to allow midstream changes to device trials as part of effort to speed up approvals
25 May 2015
The FDA continued its focus on improving the clinical trial paradigm with this week's issuance of a draft guidance on adaptive designs for medical device clinical studies. Similar to a prior guidance on the incorporation of patient preference data in clinical trials, the latest guidance should help companies perform trials faster, and signals greater flexibility on the behalf of the FDA.
India developing federal medical device surveillance system
25 May 2015
The Indian government is developing a system of medical device surveillance and adverse event reporting, dubbed the Materio-vigilance Programme of India.
Gilead's Sovaldi faces renewed advocacy CL pressure, this time for China and Russia
25 May 2015
China and Russia have become new targets for compulsory-licensing campaigns as an activist group widens its global challenge to Gilead's ($GILD) expensive Sovaldi (sofosbuvir) hepatitis C drug.
Australia launches clinical trials website to sharpen patient access for PhIII
22 May 2015
Australia launched an online register of clinical trials so that patients can search for potential treatment opportunities as recruitment falls short for many Phase III efforts in the country, the Australian newspaper reported.
NIH announces winning teams of Neuro Startup Challenge to commercialize its inventions
22 May 2015
The National Institutes of Health announced the 16 winning teams of the Neuro Startup Challenge. They were chosen to commercialize its unlicensed technologies to improve brain health
Japan eyes higher target for generics despite missing earlier aims
22 May 2015
Although it has not even reached its goal of generics comprising 60% of drugs prescribed in Japan, the government is about to raise it to 80% or 90%, according to reports.
Moral imperatives and slippery slopes: Seeking bioethical consensus
22 May 2015
Just because we can, should we? One of humanity's age-old questions took center stage at the two-day BEINGS 2015 meeting, during which delegates began laying the groundwork for what is hoped to become a consensus document setting ethical principles, policies and guidelines in the area of cellular biotechnology, which includes stem cell science and the rapidly advancing gene-editing technologies.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Russian drug for the treatment of viral hepatitis will be exempt from duty in Mongolia
24 April 2024
PM Mishustin: “We need to increase the production of vital and essential drugs in Russia”
24 April 2024
The Future of Pharmacy: How Advancements in Technology Are Transforming the Field
23 April 2024
Analysis Forecasts Up to 16.5% of Population Will Have Chronic Kidney Disease by 2032
23 April 2024